Metrifonate in Alzheimer's disease: less caregiver burden

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1235, 2000-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment, Measures and Approaches to Easing Caregiver Burden in Alzheimer's Disease

By Farcnik K. Persyko M.S.

Drugs & Aging, Vol. 19, Iss. 3, 2002-01 ,pp. : 203-215

Adis International

Access to resources Recommend Favorite

Metrifonate: A Review of its Use in Alzheimers Disease

By Ormrod D. Spencer C.

CNS Drugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 443-467

Adis International

Access to resources Recommend Favorite

Does Pharmacological Treatment of Neuropsychiatric Symptoms in Alzheimer's Disease Relieve Caregiver Burden?

By Levy Karen Lanctôt Krista L. Farber Shale B. Li Abby Herrmann Nathan

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 167-179

Adis International

Access to resources Recommend Favorite

Impact of Rivastigmine on Caregiver Burden Associated with Alzheimer's Disease in Both Informal Care and Nursing Home Settings

By Grossberg George T.

Drugs & Aging, Vol. 25, Iss. 7, 2008-01 ,pp. : 573-584

Adis International

Access to resources Recommend Favorite

Defining the Role of the Caregiver in Alzheimer's Disease Treatment

By Brodaty H.

Drugs & Aging, Vol. 19, Iss. 12, 2002-01 ,pp. : 891-898

Adis International

Access to resources Recommend Favorite